The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Contraceptive Drug Market Research Report 2025
Synopsis
Contraceptives (birth control pills) are medications that prevent pregnancy. They are one method of birth control.
The global Contraceptive Drug market was valued at US$ 13450 million in 2023 and is anticipated to reach US$ 20340 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
The contraceptive drug market is projected to experience significant growth in the foreseeable future. Factors such as increasing awareness about family planning, rising demand for effective birth control methods, and advancements in contraceptive drug formulations drive market growth. The market is highly competitive, with several pharmaceutical companies offering a wide range of contraceptive drugs. However, challenges such as potential side effects, adherence issues, and cultural barriers may hinder market expansion. Nonetheless, the contraceptive drug market holds promising opportunities, driven by the need for safe and convenient contraceptive options, and the growing focus on reproductive health and family planning worldwide.
This report aims to provide a comprehensive presentation of the global market for Contraceptive Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptive Drug.
Report Scope
The Contraceptive Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contraceptive Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contraceptive Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cipla
Bayer
Merck
Teva Pharmaceutical
AbbVie
Pfizer
Reckitt Benckiser
Mankind Pharma
Janssen Pharmaceutical
HLL Lifecare
Mithra Pharmaceuticals
Segment by Type
Oral Contraceptives
Contraceptive Injectable
Topical Contraceptive Patch
Segment by Application
Hospital Pharmacy
Independent Pharmacy
Online Platform
Clinics
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Contraceptive Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Contraceptive Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Contraceptives (birth control pills) are medications that prevent pregnancy. They are one method of birth control.
The global Contraceptive Drug market was valued at US$ 13450 million in 2023 and is anticipated to reach US$ 20340 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
The contraceptive drug market is projected to experience significant growth in the foreseeable future. Factors such as increasing awareness about family planning, rising demand for effective birth control methods, and advancements in contraceptive drug formulations drive market growth. The market is highly competitive, with several pharmaceutical companies offering a wide range of contraceptive drugs. However, challenges such as potential side effects, adherence issues, and cultural barriers may hinder market expansion. Nonetheless, the contraceptive drug market holds promising opportunities, driven by the need for safe and convenient contraceptive options, and the growing focus on reproductive health and family planning worldwide.
This report aims to provide a comprehensive presentation of the global market for Contraceptive Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptive Drug.
Report Scope
The Contraceptive Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contraceptive Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contraceptive Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cipla
Bayer
Merck
Teva Pharmaceutical
AbbVie
Pfizer
Reckitt Benckiser
Mankind Pharma
Janssen Pharmaceutical
HLL Lifecare
Mithra Pharmaceuticals
Segment by Type
Oral Contraceptives
Contraceptive Injectable
Topical Contraceptive Patch
Segment by Application
Hospital Pharmacy
Independent Pharmacy
Online Platform
Clinics
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Contraceptive Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Contraceptive Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Contraceptive Drug Market Overview
1.1 Product Overview and Scope of Contraceptive Drug
1.2 Contraceptive Drug Segment by Type
1.2.1 Global Contraceptive Drug Market Value Comparison by Type (2024-2030)
1.2.2 Oral Contraceptives
1.2.3 Contraceptive Injectable
1.2.4 Topical Contraceptive Patch
1.3 Contraceptive Drug Segment by Application
1.3.1 Global Contraceptive Drug Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Independent Pharmacy
1.3.4 Online Platform
1.3.5 Clinics
1.4 Global Contraceptive Drug Market Size Estimates and Forecasts
1.4.1 Global Contraceptive Drug Revenue 2019-2030
1.4.2 Global Contraceptive Drug Sales 2019-2030
1.4.3 Global Contraceptive Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Contraceptive Drug Market Competition by Manufacturers
2.1 Global Contraceptive Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Contraceptive Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Contraceptive Drug Average Price by Manufacturers (2019-2024)
2.4 Global Contraceptive Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Contraceptive Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Contraceptive Drug, Product Type & Application
2.7 Contraceptive Drug Market Competitive Situation and Trends
2.7.1 Contraceptive Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Contraceptive Drug Players Market Share by Revenue
2.7.3 Global Contraceptive Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Contraceptive Drug Retrospective Market Scenario by Region
3.1 Global Contraceptive Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Contraceptive Drug Global Contraceptive Drug Sales by Region: 2019-2030
3.2.1 Global Contraceptive Drug Sales by Region: 2019-2024
3.2.2 Global Contraceptive Drug Sales by Region: 2025-2030
3.3 Global Contraceptive Drug Global Contraceptive Drug Revenue by Region: 2019-2030
3.3.1 Global Contraceptive Drug Revenue by Region: 2019-2024
3.3.2 Global Contraceptive Drug Revenue by Region: 2025-2030
3.4 North America Contraceptive Drug Market Facts & Figures by Country
3.4.1 North America Contraceptive Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Contraceptive Drug Sales by Country (2019-2030)
3.4.3 North America Contraceptive Drug Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Contraceptive Drug Market Facts & Figures by Country
3.5.1 Europe Contraceptive Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Contraceptive Drug Sales by Country (2019-2030)
3.5.3 Europe Contraceptive Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Contraceptive Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Contraceptive Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Contraceptive Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Contraceptive Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Contraceptive Drug Market Facts & Figures by Country
3.7.1 Latin America Contraceptive Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Contraceptive Drug Sales by Country (2019-2030)
3.7.3 Latin America Contraceptive Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Contraceptive Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Contraceptive Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Contraceptive Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Contraceptive Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Contraceptive Drug Sales by Type (2019-2030)
4.1.1 Global Contraceptive Drug Sales by Type (2019-2024)
4.1.2 Global Contraceptive Drug Sales by Type (2025-2030)
4.1.3 Global Contraceptive Drug Sales Market Share by Type (2019-2030)
4.2 Global Contraceptive Drug Revenue by Type (2019-2030)
4.2.1 Global Contraceptive Drug Revenue by Type (2019-2024)
4.2.2 Global Contraceptive Drug Revenue by Type (2025-2030)
4.2.3 Global Contraceptive Drug Revenue Market Share by Type (2019-2030)
4.3 Global Contraceptive Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Contraceptive Drug Sales by Application (2019-2030)
5.1.1 Global Contraceptive Drug Sales by Application (2019-2024)
5.1.2 Global Contraceptive Drug Sales by Application (2025-2030)
5.1.3 Global Contraceptive Drug Sales Market Share by Application (2019-2030)
5.2 Global Contraceptive Drug Revenue by Application (2019-2030)
5.2.1 Global Contraceptive Drug Revenue by Application (2019-2024)
5.2.2 Global Contraceptive Drug Revenue by Application (2025-2030)
5.2.3 Global Contraceptive Drug Revenue Market Share by Application (2019-2030)
5.3 Global Contraceptive Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Cipla
6.1.1 Cipla Corporation Information
6.1.2 Cipla Description and Business Overview
6.1.3 Cipla Contraceptive Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Cipla Contraceptive Drug Product Portfolio
6.1.5 Cipla Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Contraceptive Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Contraceptive Drug Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Contraceptive Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Contraceptive Drug Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Teva Pharmaceutical
6.4.1 Teva Pharmaceutical Corporation Information
6.4.2 Teva Pharmaceutical Description and Business Overview
6.4.3 Teva Pharmaceutical Contraceptive Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceutical Contraceptive Drug Product Portfolio
6.4.5 Teva Pharmaceutical Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Corporation Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Contraceptive Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AbbVie Contraceptive Drug Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Contraceptive Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Contraceptive Drug Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Reckitt Benckiser
6.6.1 Reckitt Benckiser Corporation Information
6.6.2 Reckitt Benckiser Description and Business Overview
6.6.3 Reckitt Benckiser Contraceptive Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Reckitt Benckiser Contraceptive Drug Product Portfolio
6.7.5 Reckitt Benckiser Recent Developments/Updates
6.8 Mankind Pharma
6.8.1 Mankind Pharma Corporation Information
6.8.2 Mankind Pharma Description and Business Overview
6.8.3 Mankind Pharma Contraceptive Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mankind Pharma Contraceptive Drug Product Portfolio
6.8.5 Mankind Pharma Recent Developments/Updates
6.9 Janssen Pharmaceutical
6.9.1 Janssen Pharmaceutical Corporation Information
6.9.2 Janssen Pharmaceutical Description and Business Overview
6.9.3 Janssen Pharmaceutical Contraceptive Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Janssen Pharmaceutical Contraceptive Drug Product Portfolio
6.9.5 Janssen Pharmaceutical Recent Developments/Updates
6.10 HLL Lifecare
6.10.1 HLL Lifecare Corporation Information
6.10.2 HLL Lifecare Description and Business Overview
6.10.3 HLL Lifecare Contraceptive Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 HLL Lifecare Contraceptive Drug Product Portfolio
6.10.5 HLL Lifecare Recent Developments/Updates
6.11 Mithra Pharmaceuticals
6.11.1 Mithra Pharmaceuticals Corporation Information
6.11.2 Mithra Pharmaceuticals Contraceptive Drug Description and Business Overview
6.11.3 Mithra Pharmaceuticals Contraceptive Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mithra Pharmaceuticals Contraceptive Drug Product Portfolio
6.11.5 Mithra Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Contraceptive Drug Industry Chain Analysis
7.2 Contraceptive Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Contraceptive Drug Production Mode & Process
7.4 Contraceptive Drug Sales and Marketing
7.4.1 Contraceptive Drug Sales Channels
7.4.2 Contraceptive Drug Distributors
7.5 Contraceptive Drug Customers
8 Contraceptive Drug Market Dynamics
8.1 Contraceptive Drug Industry Trends
8.2 Contraceptive Drug Market Drivers
8.3 Contraceptive Drug Market Challenges
8.4 Contraceptive Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
